EXCLUSIVE | Inside SA's R1.5bn deal with Johnson & Johnson and possible vaccine delivery delays

Share your Subscriber Article
You have 5 articles to share every month. Send this story to a friend!
0:00
play article
Subscribers can listen to this article
A clinical trial volunteer participates in Johnson & Johnson's study to test a coronavirus vaccine.
A clinical trial volunteer participates in Johnson & Johnson's study to test a coronavirus vaccine.
Janssen

Millions of Johnson & Johnson Covid-19 vaccine doses expected to arrive in the country from April may be delayed by weeks because of a failure by the government to timeously meet a key contract clause in its agreement with the US-based drug maker.

The clause calls for the government to set up a no-fault compensation (NFC) mechanism to cover damage claims arising from unlikely but potential adverse effects in people who get the jabs – but this system is yet to be set up, and News24 has learned that the government was aware, since at least early February, that it would have to be put in place. 

There’s more to this story
Subscribe to News24 and get access to our exclusive journalism and features today.
Subscribe
Already a subscriber? Sign in
Lockdown For
DAYS
HRS
MINS
Voting Booth
As a child or as an adult, have you ever been a victim of bullying?
Please select an option Oops! Something went wrong, please try again later.
Results
Yes, at school
55% - 4336 votes
Yes, at work
18% - 1403 votes
No, I've never experienced this
28% - 2185 votes
Vote
USD/ZAR
14.27
(-0.3)
GBP/ZAR
19.82
(+0.1)
EUR/ZAR
17.19
(+0.0)
AUD/ZAR
11.04
(+0.1)
JPY/ZAR
0.13
(-0.2)
Gold
1,785.45
(+0.1)
Silver
26.10
(-0.2)
Platinum
1,212.65
(+0.5)
Brent Crude
65.40
(+0.1)
Palladium
2,840.21
(+0.1)
All Share
66,817
(-0.2)
Top 40
61,053
(-0.2)
Financial 15
12,065
(-0.3)
Industrial 25
86,662
(-0.2)
Resource 10
68,435
(-0.3)
All JSE data delayed by at least 15 minutes Iress logo